FIM
ALNY icon

Foresters Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Foresters Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,386
Closed -$176K – 399
2017
Q4 		$176K Buy
+1,386
New +$174K ﹤0.01% 509

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Foresters Investment Management's ALNY Position: Q1 2018 in Review

Foresters Investment Management sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2018, closing a stake of 1,386 shares — an estimated $176K sold.

Foresters Investment Management first reported a position in ALNY in Q4 2017 and held it in 1 quarter. The position peaked at $176K in Q4 2017. 292 funds tracked by Wall St. Rank hold ALNY as of Q1 2018.

  • Foresters Investment Management reported no remaining Alnylam Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Foresters Investment Management sold 1,386 Alnylam Pharmaceuticals shares in Q1 2018, an estimated $176K.
  • Foresters Investment Management first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Foresters Investment Management's Alnylam Pharmaceuticals position peaked at $176K in Q4 2017.
  • 292 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2018.

Based on Foresters Investment Management's 13F filing for Q1 2018, filed 11 May 2018.